Literature DB >> 20175036

Mouse models of hepatocellular carcinoma.

Nelson Fausto1, Jean S Campbell.   

Abstract

The etiology of liver cancer is well known, but despite recent progress in the application of molecular techniques for the analysis of the development of these tumors, we still lack precise knowledge about pathogenesis of hepatocellular carcinoma (HCC). Animal models can provide essential knowledge about HCC pathogenesis, particularly if they mimic the tissue environment in which human tumors develop. The synergism between studies in animal models and human tumors is strengthened by using comparative genomic analysis to identify genes and pathways that are critical for both mouse and human oncogenesis. In this article, the authors discuss some selective examples of constitutive, conditional, and inducible models of HCC development, and briefly describe the genetic manipulations required for engineering these models and some new techniques used for gene screening in HCC. The authors focus on models that best correlate with the human disease and offer important insights into the pathogenesis of HCC.

Entities:  

Mesh:

Year:  2010        PMID: 20175036     DOI: 10.1055/s-0030-1247135

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  49 in total

Review 1.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

Authors:  Elizabeth Brandon-Warner; Tracy L Walling; Laura W Schrum; Iain H McKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

3.  Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.

Authors:  Xing Wang; Juan Zhang; Liang Zhou; Peng Lu; Zhi-Gang Zheng; Wei Sun; Jian-Lin Wang; Xi-Sheng Yang; Xiao-Lei Li; Ning Xia; Ning Zhang; Ke-Feng Dou
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

Review 5.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

6.  Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression.

Authors:  Suzanne A Hartford; Yunhai Luo; Teresa L Southard; Irene M Min; John T Lis; John C Schimenti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

7.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc Pharmacol       Date:  2014-09-02

Review 8.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

Review 9.  Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

Authors:  Kwang Il Kim; Hye Kyung Chung; Ju Hui Park; Yong Jin Lee; Joo Hyun Kang
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 10.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.